Dr Dana Wong is a Clinical Neuropsychologist and Associate Professor in the School of Psychology and Public Health at La Trobe University. She leads the eNACT (Neurorehabilitation And Clinical Translation) Research Group and Clinic, which focuses on innovative neurorehabilitation techniques to improve the lives of acquired brain injury survivors, and enhancing clinical implementation of these evidence-based intervention techniques. She received the La Trobe University 2020 Research Engagement and Impact Award. She has published over 60 peer-reviewed journal articles, several book chapters, and a treatment manual on Cognitive Behaviour Therapy Adapted for Brain Injury (CBT-ABI). Dana’s focus on training top scientist-practitioners as a key element to clinical translation has been recognised with several awards for teaching excellence and clinical innovation. She is President-Elect of the Australasian Society for the Study of Brain Impairment and an Editorial Board member for the journal Brain Impairment. In 2017 she led the development of BRAINSPaN, a multidisciplinary community of practice of clinicians and researchers in the brain impairment field. She also leads an advocacy group for the Australian Psychological Society’s College of Clinical Neuropsychologists, advocating for better community awareness and funding to support the training and workforce of clinical neuropsychologists.

After 11+ entry to Bristol Grammar School David was awarded an Open Scholarship to Downing College Cambridge and then completed his medical training at Guy’s Hospital London, continuing in neurology to MRCP. After completing his psychiatric training in Oxford, he continued there as a lecturer and then later as a Wellcome Senior Fellow in psychiatry. He then spent two years as Chief of the Section of Clinical Science in the National Institute of Alcohol Abuse and Alcoholism in NIH, Bethesda, USA. On returning to England in 1988 he set up the Psychopharmacology Unit in Bristol University, an interdisciplinary research grouping spanning the departments of Psychiatry and Pharmacology before moving to Imperial College London in December 2008 where he leads a similar group with a particular focus on brain imaging especially PET.
David is currently Chair of DrugScience (formally the Independent Scientific Committee on Drugs (ISCD) and President of the European Brain Council. previously he has been President of the European College of Neuropsychopharmacology (ECNP), the British Neuroscience Association (BNA) and the British Association of Psychopharmacology (BAP). In addition he is a Fellow of the Royal Colleges of Physicians and of Psychiatrists and a Fellow of the Academy of Medical Sciences. He is also the UK Director of the European Certificate and Masters in Affective Disorders Courses and a member of the International Centre for Science in Drug Policy. He has edited the Journal of Psychopharmacology for over two decades and acts as the psychiatry drugs advisor to the British National Formulary. He has published over 400 original research papers, a similar number of reviews and books chapters, eight government reports on drugs and 27 books.
Previously he has been a member and then Chair of the Advisory Committee on the Misuse of Drugs (ACMD 1998-2009), a member of the HEFCE/NHS Senior Lecturer Selection Panel and of the MRC Neuroscience Board. Other previous national contributions include serving as the medical expert on the Independent Inquiry into the Misuse of Drugs Act (2000 Runciman report), and membership of the Committee on Safety of Medicines, the Committee on NHS drugs and the Ministry of Defence Science Advisory Board. He was the clinical scientific lead on the 2004/5 UK Government Foresight initiative Brain science, addiction and drugs that provided a 25-year vision for this area of science and public policy.
David broadcasts widely to the general public both on radio and television including BBC science and public affairs programmes on therapeutic as well as illicit drugs, their harms and their classification. He also lecturers widely to the public as well as to the scientific and medical communities; for instance has presented three time at the Cheltenham Science Festival and several times for Café Scientifiques. In 2010 The Times Eureka science magazine included him in the 100 most important figures in British Science, and the only psychiatrist.

I am a Clinical Nurse Consultant & Clinical Sexologist. I have been nursing for 45 years & have qualifications in the areas of Midwifery, Family Planning, Masters in Sexual Health & currently completing my Doctorate in Public Health. I am the Nurse Manager of the HIV/Sexual & Reproductive Health Clinic & I also run my own nurse-provider LARC clinic at Barwon University Hospital Geelong. I work privately within a group practice as a Clinical Sexologist at Barwon Consulting Suites, Geelong. I have presented nationally & internationally across a variety of sexual & reproductive health topics, including contraception, termination, sexual dysfuntion, & sexual pleasure. I have 4 adult children I am proud of, I love cooking & entertaining & I look forward to travelling anywhere, once again!

Nurse Educator for Epidermolysis Bullosa with Independence Australia, current administrators for the National Epidermolysis Bullosa Dressing Scheme, funded by the federal Government.
Clinical Nurse Consultant Dermatology/Epidermolysis Bullosa at Sydney Children’s Hospital, Randwick.
Experienced paediatric clinical nurse consultant specialising in dermatology, rare disease work, with primary focus in Epidermolysis Bullosa. Demonstrated history of chronic and complex care coordination within hospital and community settings. Highly skilled in health education, Health Promotion, and Project development. Masters of International Public Health from UNSW.

Prof Dominic Dwyer is a medical virologist and infectious diseases physician in the Centre for Infectious Diseases and Microbiology Laboratory Services, located in the ICPMR at Westmead Hospital, Sydney. He has a clinical and research interest in viral diseases of public health importance. This includes HIV (where he coordinates an active program in antiretroviral drug resistance and HIV molecular epidemiology in Australia and the region), influenza and other respiratory viruses, and arboviruses. He leads an antiviral trials unit that has participated in over sixty studies of antiviral drugs and vaccines. His influenza research includes assessing interventions to prevent influenza transmission in closed environments, and developing assays for seasonal and pandemic influenza. CIDMLS has enhanced the laboratory investigative capacity in NSW for infectious disease outbreaks, with his particular focus being rapid detection and molecular epidemiology of outbreak and emerging viruses.

Rick Doblin, Ph.D., is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master’s thesis on a survey of oncologists about smoked marijuana vs. the oral THC pill in nausea control for cancer patients. His undergraduate thesis at New College of Florida was a 25-year follow-up to the classic Good Friday Experiment, which evaluated the potential of psychedelic drugs to catalyze religious experiences. He also conducted a thirty-four year follow-up study to Timothy Leary’s Concord Prison Experiment. Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist. He founded MAPS in 1986, and currently resides in Boston with his wife, dog, and empty rooms from three children, one of whom is in college and two have graduated.

Dr Blackwell is a general adult Psychiatrist in private practice with a long standing interest in sleep and insomnia and their intimate relationships with all psychiatric illnesses and general psychological development.

Wendy has a medical degree and worked for many years in general practice. She has completed post graduate training in allergy through the University of Western Sydney and worked in the allergy department at the Royal Melbourne Hospital until 2021. She also currently works part time at the Centre for Food Allergy Research (CFAR) which is part of the Murdoch Children’s Research Institute (MCRI) in Melbourne. Wendy has done volunteer work for Allergy & Anaphylaxis Australia (A&AA) for 15 years and since the start of 2021 has been employed there as a Health Management Educator.
Two of Wendy’s three teenage children are at risk of anaphylaxis to multiple foods (egg, dairy, fish, kiwi fruit, sesame seed, cashew, and pistachio) and so she has many years’ experience with the daily management of food allergies.
Wendy is an associate member of the Australasian Society of Clinical Immunology and Allergy (ASCIA). She has been involved with the National Allergy Strategy since its inception in 2015 on steering and project committees and is passionate about improving the lives of people living with allergy.

Professor Danielle Mazza is the Head of the Department of General Practice at Monash University and a nationally and internationally recognised leader in implementation research and knowledge translation in the general practice setting. She has made significant, sustained and ongoing contributions to advance general practice and primary health care in Australia in the field of women’s sexual and reproductive health and as a proponent of evidence-based quality improvement through guideline development and implementation. She leads the NHMRC Centre of Research Excellence in Sexual and Reproductive Health for Women in Primary Care (SPHERE), which aims to improve the quality, safety, and capacity of primary health care services to achieve better outcomes in women’s sexual and reproductive health.

Dr Geraldine Goss who is the Secretary of the Ovarian Cancer Research Foundation.
Dr Goss is a medical oncologist with a focus on treating and caring for women with breast and gynaecological cancers. She is also a proud advocate for raising awareness and advocating for increased research funding for ovarian cancer.
Geraldine graduated from the university of Melbourne in 1987. She undertook postgraduate training in oncology at the Royal Melbourne and Repatriation Hospitals, after which she undertook laboratory-based research as a Breast Cancer Fellow. She completed her MD thesis then travelled to Boston, USA where she completed fellowships at St Elizabeth’s Medical Centre and the Dana Farber Cancer Institute. Here she developed her interest in gynaecological cancers. Following her return to Australia in 2000, she completed a¯Masters¯degree in Women’s Health at the University of Melbourne. She now works as a medical oncologist with a focus on caring for women with breast and gynaecological cancers.

Dr Clarnette is a Consultant Physician in Geriatric Medicine at Fremantle hospital and directs the Memory Evaluation Unit at the Fremantle hospital which provides comprehensive neuro-psychological evaluation for patients with cognitive and behavioural deficits.
Dr Clarnette is the Principal Investigator for the Clinical Trials Unit at the Australian Alzheimer’s Research Foundation, where a variety of drugs are trialled for potential use in people with the early signs of Alzheimer’s disease.